Faron Pharma, Rentschler sign supply, manufacturing pact
Under the pact, Rentschler is expected to take up the responsibility of the sole global manufacturer of IFN-beta 1a for Faron and it will also manufacture Faron’s proprietary
WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.